Andrew Micieli Profile picture
Aug 22 12 tweets 3 min read
🧵
Primary care follow-up for stroke patients carries many nuances and guideline recommendation updates. In this thread we outline one possible approach with 5️⃣ issues to be addressed.

#neurotwitter #stroke @OntarioCollege @ABFamDocs @CMA_Docs. cc: @draravindganesh
Case:
A 76F is admitted to stroke ward after suffering a L MCA stroke- undergoing thrombolysis & endovascular therapy. She makes an excellent functional recovery from her stroke and is discharged home with primary care follow up in 1-2 weeks, and specialist follow up in 3-months
1⃣Review antithrombotic meds

DOACs are now preferred over warfarin for stroke prevention in Afib. Given their short 1/2 lives, compliance is extremely important as missed doses result in⬇️stroke protection. Reminders at each clinic visit is important and cost effective strategy
2⃣ 🇨🇦guideline updates to secondary prevention optimization

More aggressive sBP target of < 130mmHg is recommended for subcortical (lacunar) strokes.

LDL target < 1.8mmol/L (rather than <2.0) in patients with symptomatic atherosclerosis which often requires add-on therapies...
if highest tolerated statin dose has not reached target. In patients with diabetes on standard oral meds not at < 7% A1c target, the addition of SGLT-2 inhibitor or GLP-1 receptor agonist is recommended. At each visit, discussion about lifestyle modification is encouraged.
3⃣ Have a guideline recommended perioperative plan for if and how long to hold antithrombotics

At each visit patients should be asked about upcoming procedures/surgeries with a plan in place regarding perioperatively dosing (see Thrombosis Canada website)...
Specifically regarding dental procedures (minimal bleed risk procedure), the morning-of dose may be skipped to avoid peak anticoagulant effect during surgery with resumption 4-6 hours after procedure.
4⃣ Opportunistic screening for Afib

An update to the 2020 Canadian Stroke Best Practice Guidelines is to complete routine pulse checks or ECG at follow-up visits in individuals >65 years old after stroke.
Frequent follow-up ECGs will likely result in clinically meaningful Afib detection. More invasive and prolonged cardiac monitoring may be indicated at the discretion of the stroke neurologist.
5⃣End of visit reminder when to call 🚑

Review FAST mnemonic—Face (facial droop), Arm (unilateral arm weakness), Speech (speech difficulty), & Time. Tremendous advances in acute stroke Rx (such as EVT) can reverse the effects of stroke if initiated very early after symptom onset
Case cont'd:
In primary care follow-up our patient's statin was⬆️as they were tolerating without side effects the initial dose started in hospital, & indapamide 1.25mg was added to their perindopril 8mg for further BP optimization to persistently achieve a target of <130/80mmHg

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Andrew Micieli

Andrew Micieli Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MicieliA_MD

May 21
🚨Acute #stroke case (from the archive):

Patient in 60s presents with sudden onset fluctuating LOC, dysarthria, mild right arm weakness (disabling)

Last seen normal 2hrs (witnessed onset).

You urgently take to CT- motion artifact, no clear early ischemic changes. CTA normal. Image
2 schools of thought/approaches:

Approach #1⃣: Acute onset, disabling symptoms- proceed with lytic 💉and defer CTP

Approach #2⃣: Dx is still a bit unclear (ddx: seizure⚡️, etc)- proceed to CTP

If in camp #2, here are the CTP maps (CBF, MTT, Tmax>8s) Image
CTP confirms suspected localization of left thalamus (with possible internal capsule involvement).

CTP helped confirm the etiology (not a mimic), but delayed lytic administration by about 7-10 min (did not change management).

Which camp/approach are you in for this case🧠?
Read 4 tweets
May 3, 2021
The tPA recommendation on the NNT website changed to "the net benefit & harms are unclear due to uncertainty of data" authored by @TheSGEM

I believe it's helpful to clarify a few points on this debate so we present families with correct info before they make a decision on tPA.
1. The main source for the recommendation is from a review paper in Emerg Med Australasia (see below).

This paper includes all thrombolytics (anistreplase, streptodornase, streptokinase, urokinase, lumbrokinase, duteplase, lanoteplase, pamiteplase, etc)

pubmed.ncbi.nlm.nih.gov/27561375/
Clumping the data to include all thrombolytics is not helpful, as only alteplase (tPA) is clinically used. We have moved on from the old thrombolytics.

When studying the new thrombolytic Tenecteplase in a RCT, we will not compare it to streptokinase. Thats not helpful.
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(